BackGenomtec S.A. Overview
Genomtec S.A.

Genomtec S.A. Return on Equity

Valuation check: GMT.WA's ROE is -51.96%, below the sector sector average of 11.67%.

Get informed when a big investor buys or sells

+ Follow

ROE

-51.96%

Return on Equity

-51.96%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Genomtec S.A. (GMT.WA) FAQ

Genomtec S.A. (GMT.WA) currently reports a ROE of -51.96%. That is below the sector sector average of 11.67%. Use the charts on this page to explore Genomtec S.A.'s ROE history and peer comparisons.

Genomtec S.A.'s ROE of -51.96% is lower than the its sector sector average of 11.67%. That is roughly 545.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Genomtec S.A.'s current -51.96% should be judged against industry norms (sector average: 11.67%) and against GMT.WA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -51.96%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.67%. From there, open related valuation or income-statement pages for Genomtec S.A., and consider following GMT.WA for alerts when major investors trade the stock.